Antibe Therapeutics Inc. (ATE) Fundamentals

Antibe Therapeutics Inc is leveraging its proprietary hydrogen sulfide platform to develop next-generation safer therapies to target inflammation arising from a wide range of medical conditions. The company's pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs. Antibe's lead drug, otenaproxesul, is in clinical development as a safer alternative to opioids for post-operative pain. Antibe's second pipeline drug, ATB-352, is being developed for a specialized acute pain indication. The company's anticipated next target is inflammatory bowel disease, a condition long in need of safer, more effective therapies.
SHARE INFORMATION
Market Cap$ 32 301 551
Shares Outstanding52 119 276
Float43 365 703
Percent Float83,24%
Short Interest52 503,00
Short Percent Float100,0%
Short Interest Ratio1,1981
Short Interest Date2022-07-31
Latest Fiscal Dividend Per Share$ 0,00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0,50
Latest Fiscal Date2022-03-31
DIVIDENDS
Dividend (3 Years)$ 0,00
Dividend (5 Years)$ 0,00
Ex Dividend Date-
Dividend Rate$ 0,00
Dividend Yield0,0%
Payment Cash-
HOLDERS
Institutions2
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months-
Institutional Holdings Percent0,6%
Institutional Sold Previous 3 Months-
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0,0
Insider Sold Previous 3 Months-
Insider Shares Owned8 733 573
TRADING INFO
52 Week High$ 1,56
52 Week Low$ 0,56
52 Week High Change$ -54,93
21 Day Moving Average$ 0,601429
21 Day Extended Moving Average$ 0,607232
50 Day Moving Average$ 0,629
50 Day Extended Moving Average$ 0,627677
200 Day Moving Average$ 0,7111
200 Day Extended Moving Average$ 0,982923
10 Day Average Volume17 716
20 Day Average Volume25 463
30 Day Average Volume25 946
50 Day Average Volume26 751
Alpha0.017194
Beta-0.046177
Standard Deviation0.221006
R28.0E-5
7 Day Price Change$ 0,04
7 Day Percent Change6,67%
21 Day Price Change$ 0,05
21 Day Percent Change8,47%
30 Day Price Change$ 0,04
30 Day Percent Change6,67%
Month to Date Price Change$ 0,04
Month to Date Percent Change6,67%
Quarter to Date Price Change$ 0,03
Quarter to Date Percent Change4,92%
180 Day Price Change$ -0,04
180 Day Percent Change-5,88%
200 Day Price Change$ -0,11
200 Day Percent Change-14,67%
Year to Date Price Change$ -0,02
Year to Date Percent Change-3,03%

Antibe Therapeutics Inc. (ATE) Key Ratios

PROFITABILITY
EBIT Margin-271,0%
EBITDA Margin-267,9%
Pre-Tax Profit Margin-110,6%
Profit Margin Count0,0%
Gross Margin62,2%
Profit Margin TOT0,0%
INCOME STATEMENTS
Revenue$ -2 727 000
Revenue Per Share$ -0,052322
Revenue (3 Years)$ 0,00
Revenue (5 Years)$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book1,09
Total Debt To Equity0,00
Int Coverage-3 155,30
Current Ratio13,10
Leverage Ratio1,60
Quick Ratio11,90
Long Term Debt To Capital0,00
VALUATION MEASURES
PE Ratio-1,30
Enterprise Value$ -21 463 464
Price to Sales-12,2319
Price to Free Cash-2,80
PE High Last 5 Years-7,90
Price To Book0,59
Price To Cash Flow5,30
PE Low Last 5 Years-4,70
Price to Tangible Book1,09
MANAGEMENT EFFECTIVENESS
Receivables Turnover-1,40
Invoice Turnover1,40
Assets Turnover0,00
Return Assets-30,20
Return on Equity-48,17
Return on Capital-47,26

Antibe Therapeutics Inc. (ATE) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEODaniel Legault
Emplyoees26
Last AuditUE
CIK0001583682
IndustryMedical Devices & Instruments
SectorHealthcare
NAICSIn-Vitro Diagnostic Substance Manufacturing(325413)
CONTACT INFO
Address15 Prince Arthur Avenue
Toronto, ON M5R 1B2
Websitehttps://www.antibethera.com
Facsimile-
Telephone+1 905 570-5103
Email-
Dernières Valeurs Consultées
TSX
ATE
Antibe The..
Inscrivez-vous aujourd'hui pour consulter ce titre en streaming sur le Moniteur ADVFN. Vous pourrez ajouter et visualiser jusqu'à 110 des vos actions préférée et c'est complètement gratuit..

Se connecter à ADVFN
S'inscrire maintenant
Les cours EURONEXT (CAC 40, etc. ) et FOREX (les devises) sont en direct si connecté.
NYSE, AMEX, et ASX sont en différé d'environ 20 minutes. Les autres cours sont en différé d'environ 15 minutes.

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

P: V:fr D:20220811 14:57:39